Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-17

Clinical Trial Update: A Study in Healthy People to Test Whether BI 730357 Affects How 4 Other Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Taken up in the Body [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the effect of BI 730357 on the pharmacokinetics of four other medicines (rosuvastatin, digoxin, metformin, and furosemide) in healthy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BI 730357
  • DIGOXIN (Digoxin)
  • FUROSEMIDE (Furosemide)
  • Rosuvastatin (rosuvastatin)
  • metformin (metformin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Healthy | Phase 1 | Status: COMPLETED | Results posted: 2023-07-17